Geisinger at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Geisinger brings 5 presentations to IDWeek 2026 in Washington. Its program centres on infection prevention in the hospital and on using health records to study infections. One clinical trial tests whether universal intranasal decolonization without antibiotics lowers hospital-onset bloodstream infections in adult intensive care units.
| Organization | IDWeek 2026 Attendance |
|---|---|
Geisinger Danville, PA | |
Industry Wed Oct 21 9:00am–10:00am Breakfast Symposium: Diagnostic Excellence in Syndromic Testing for GI and Respiratory Infections Diagnostics and diagnostic stewardshipRespiratory infections and COVID-19 Poster Thu Oct 22 12:15pm–1:30pm Direct Real-Time Feedback to Improve Compliance with Colorectal Surgical Site Infection Prevention Practices: A Quality Improvement Initiative Poster Thu Oct 22 12:15pm–1:30pm Validation of Lyme Disease Reinfection Using Electronic Health Records Poster Sat Oct 24 12:15pm–1:30pm Effectiveness of Seasonal Influenza Vaccination in Reducing Severe Outcomes Among Older Adults Presenting to the Emergency Department: A Retrospective Cohort Study Poster Sat Oct 24 12:15pm–1:30pm Impact of Universal Non-Antibiotic Intranasal Decolonization on Hospital-Onset Bloodstream Infections in Adult Intensive Care Units |
Instantly find 20 buyers from Geisinger
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction